Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|2|155-167

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 155-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lenalidomide delays multiple myeloma progression

By  

Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma

By Shah Sachin R.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1869-1881

Adis International

Access to resources Recommend Favorite

Current therapeutic uses of lenalidomide in multiple myeloma

By Hideshima Teru   Richardson Paul G   Anderson Kenneth C  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 171-179

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide: A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma

By Scott Lesley J.   Lyseng-Williamson Katherine A.  

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 625-649

Adis International

Access to resources Recommend Favorite

Dexamethasone/lenalidomide: Various toxicities: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite